Alkem Foundation, the corporate social responsibility arm of Alkem Laboratories Ltd., has invested INR 100 crores in the establishment of the Samprada Singh Memorial Radiotherapy Centre in Muzaffarpur, Bihar. This state-of-the-art facility is part of the newly inaugurated Homi Bhabha Cancer Hospital and Research Centre and has the capacity to treat 3,500-4,000 cancer patients annually, making it the largest in North Bihar and the second-largest in the state.
The centre is equipped with advanced technologies, including linear accelerators, stereotaxy, and in-house brachytherapy, and has been developed in collaboration with the Tata Memorial Centre in Mumbai. The goal of this centre is to provide world-class cancer treatment options to patients in Bihar and neighboring states, bridging the gap in cancer treatment in these regions.
According to Madhurima Singh, Executive Director of Alkem, the company has its roots in Bihar and is committed to giving back to the region. With cancer cases on the rise, the need for advanced facilities is greater than ever. The centre will not only provide treatment but also support patients and their families, creating a holistic model of care.
The partnership between Alkem Foundation and the Homi Bhabha Cancer Hospital and Research Centre builds on years of collaboration in screening and palliative care. The centre aims to provide complete and compassionate cancer care, including ethical and affordable evidence-based treatment, as well as education and research.
This initiative is part of Alkem Foundation’s existing cancer care programs, which include screening, awareness, and home-based palliative care. The foundation’s goal is to strengthen healthcare infrastructure and bridge treatment gaps in underserved regions. With the establishment of the Samprada Singh Memorial Radiotherapy Centre, Alkem Foundation is taking a significant step towards providing sustainable healthcare solutions that have a lasting impact on the community.